Ars Technica AI
Wednesday, June 17, 2026
Beth Mole
"Truly evil" FDA rejection of gene therapy overturned after Trump official ousted
AI-Powered Summary
Generated by callmor.ai's AI to save you time
Summary
Gene therapy company UniQure had another FDA meeting after Vinay Prasad's exit.
Original Source
This article was originally published by Ars Technica AI. Read the full original article for complete details, images, and author commentary.
Read Original ArticleWant AI working for your business?
callmor.ai builds AI products that automate your operations 24/7.
Explore AI Products